Atara Biotherapeutics, Inc. (ATRA) vs Park Dental Partners, Inc. Common Stock (PARK)

A side-by-side comparison of Atara Biotherapeutics, Inc. and Park Dental Partners, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Atara Biotherapeutics, Inc. logo
ATRA
Atara Biotherapeutics, Inc.
$84M
$9.28HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Park Dental Partners, Inc. Common Stock logo
PARK
Park Dental Partners, Inc. Common Stock
$91M
$20.20HealthcareDelayed quote: Oct 6, 2026, 2:13 PM EDT

Total return — ATRA vs PARK

growth of $100 · dividends reinvested · last 1y
ATRA -37.7% (-37.7%/yr)PARK +105.8% (+105.8%/yr)PARK compounded faster over this window
50100150200Start $1002026$62$206
ATRA PARK

ATRA vs PARK: by the numbers

  • •PARK is the larger company ($91M vs $84M market cap).
  • •Both run net losses; PARK's is the smaller (-1.41% vs -269.42% net margin).

Metrics side by side

Valuation

MetricATRAPARK
Forward P/EN/A12.17
P/S ratio13.500.36
P/B ratioN/A3.06
FCF yieldN/A5449.65%

Profitability

MetricATRAPARK
Gross margin82.44%10.89%
Operating margin29.69%-2.82%
Net margin-269.42%-1.41%
ROEN/A-11.85%
ROIC-100.35%-4.43%

Growth (annualized)

MetricATRAPARK
Revenue CAGR (5Y)56.10%N/A
Total return CAGR (5Y)-53.60%N/A

Go deeper

Full ATRA analysisFull PARK analysisInteractive comparison tool

Dig into the metrics

Atara Biotherapeutics ROEPark Dental Partners, Inc. Common Stock ROEAtara Biotherapeutics operating marginPark Dental Partners, Inc. Common Stock operating marginAtara Biotherapeutics revenue growthPark Dental Partners, Inc. Common Stock revenue growthAtara Biotherapeutics free cash flowPark Dental Partners, Inc. Common Stock free cash flow

Atara Biotherapeutics & Park Dental Partners, Inc. Common Stock appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.